Table 2

Effect of clonidine on anti-immobility effects of the 4 MAO inhibitors

MAO inhibitor; dose, mg/kgTreatment; mean period of immobility (and SEM), s% changep value
Single drug*Interaction (clonidine + MAO inhibitor)
TCP< 0.001
 0.0188 (21)NANA
 0.5204 (12)163§ (19)−17
 2.0214 (12)133§ (25)−35
 8.0170§ (15)102§ (25)−30
FTCP< 0.001
 0.0230 (2)NANA
 0.5228 (3)191 (6)−16
 2.0208 (17)173§ (11)−15
 8.0191 (13)129§ (22)−27
PLZ< 0.001
 0.0214 (6)NANA
 2.0223 (5)170 (22)−23
 8.0235 (2)143§ (21)−42
32.0231 (3)170 (13)−27
AcPLZ< 0.001
 0.0214 (6)NANA
 2.0219 (10)155§ (20)−27
 8.0228 (4)182 (11)−20
32.0211 (7)111§ (26)−43
  • Note: TCP = tranylcypromine, FTCP = 4-fluorotranylcypromine, PLZ = phenelzine, AcPLZ = N2-acetylphenelzine, NA = not applicable.

  • * For zero doses of the 4 MAO inhibitors, the data are for clonidine alone (0.06 mg/kg).

  • Calculated as (% interaction – % MAO inhibitor alone), where the percentages are calculated with respect to mean periods of immobility (and SEM) for control (vehicle). Mean period of immobility (and SEM) for controls, in seconds: TCP 231 (3), FTCP 223 (2), PLZ 222 (5) and AcPLZ 232 (3).

  • F-test.

  • § Significantly different from vehicle (p < 0.01) (Sidak’s test, n = 10).

  • Significantly different from MAO inhibitor alone (p < 0.01) (Sidak’s test, n = 10).